TCL Archive Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement. December 15, 2006
TCL Archive Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review January 13, 1978
TCL Archive In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program April 17, 1981
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004